240 related articles for article (PubMed ID: 37833609)
1. Antibodies to Domain I β
Reshetnyak TM; Cheldieva FA; Cherkasova MV; Glukhova SI; Lila AM; Nasonov EL
Dokl Biochem Biophys; 2023 Aug; 511(1):219-226. PubMed ID: 37833609
[TBL] [Abstract][Full Text] [Related]
2. IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
Reshetnyak T; Cheldieva F; Cherkasova M; Lila A; Nasonov E
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012697
[TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
4. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
7. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
8. Relevance of non-criteria antiphospholipid antibodies titers among patients with antiphospholipid syndrome and patients with systemic lupus erythematosus.
Urrego-Callejas T; Hernández A; Ruiz Giraldo S; Frade-Sosa B; Vanegas-García AL; Muñoz CH; Rua C; Duque Botero J; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2023 Apr; 19(4):197-203. PubMed ID: 37061281
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
Cabral AR; Cabiedes J; Alarcón-Segovia D
Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Samarkos M; Davies KA; Gordon C; Loizou S
Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
[TBL] [Abstract][Full Text] [Related]
13. Study of antiphospholipid antibodies by enzyme immunoassay and chemiluminescent methods in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data).
Cheldieva FA; Reshetnyak TM; Cherkasova MV; Lila AM
Klin Lab Diagn; 2021 Sep; 66(9):546-551. PubMed ID: 34543533
[TBL] [Abstract][Full Text] [Related]
14. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
15. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
16. Role of anti-domain 1-β2 glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome.
De Craemer AS; Musial J; Devreese KM
J Thromb Haemost; 2016 Sep; 14(9):1779-87. PubMed ID: 27314634
[TBL] [Abstract][Full Text] [Related]
17. [Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome].
Reshetnyak TM; Cheldieva FA; Cherkasova MV; Lila AM; Nasonov EL
Ter Arkh; 2022 Jun; 94(5):628-634. PubMed ID: 36286961
[TBL] [Abstract][Full Text] [Related]
18. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL
Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid Antibody Testing for Anti-cardiolipin and Anti-β2 Glycoprotein I Antibodies Using Chemiluminescence-Based Panels.
Favaloro EJ; Mohammed S; Vong R; Pasalic L
Methods Mol Biol; 2023; 2663():297-314. PubMed ID: 37204719
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
Bizzaro N; Tonutti E; Villalta D; Tampoia M; Tozzoli R
Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
